Open access
Open access
Powered by Google Translator Translator

Chest Medicine

FDA orders Juul to remove all its e-cigarettes from US market.

6 Jul, 2022 | 11:46h | UTC

FDA orders Juul to remove all its e-cigarettes from US market – The BMJ

See also:

FDA orders all Juul e-cigarettes off the market – POLITICO

The FDA orders Juul to pull all of its vaping products from the U.S. market – NPR

FDA orders Juul Labs to remove products from US market – CNN

FDA News Release: FDA Denies Authorization to Market JUUL Products – U.S. Food & Drug Administration


RCT | Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis.

6 Jul, 2022 | 11:31h | UTC

Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial – Thorax

Commentary: Does Azithromycin antagonize the effect of inhaled tobramycin in cystic fibrosis? – Medical Dialogues

 

Commentary on Twitter


Exercise-induced laryngeal obstruction (EILO) in athletes: a narrative review by a subgroup of the IOC Consensus on acute respiratory illness in the athlete.

5 Jul, 2022 | 11:59h | UTC

Exercise-induced laryngeal obstruction (EILO) in athletes: a narrative review by a subgroup of the IOC Consensus on ‘acute respiratory illness in the athlete’ – British Journal of Sports Medicine


M-A | Predictors of sleep disordered breathing in children with Down syndrome.

5 Jul, 2022 | 11:33h | UTC

Predictors of sleep disordered breathing in children with Down syndrome: a systematic review and meta-analysis – European Respiratory Review


Review | Cough hypersensitivity and chronic cough.

4 Jul, 2022 | 12:59h | UTC

Cough hypersensitivity and chronic cough – Nature Reviews Disease Primers (if the link is paywalled, try this one)

See also: Infographic (if the link is paywalled, try this one)

 

Commentary on Twitter


Bad news for Paxlovid? Coronavirus can find multiple ways to evade COVID-19 drug.

4 Jul, 2022 | 12:57h | UTC

Bad news for Paxlovid? Coronavirus can find multiple ways to evade COVID-19 drug – Science

See also: SARS-CoV-2 can evade Paxlovid by multiple mechanisms – News Medical


Opinion | FDA: Don’t rush a move to change the Covid-19 vaccine composition.

4 Jul, 2022 | 12:53h | UTC

FDA: Don’t rush a move to change the Covid-19 vaccine composition – STAT


Guideline | Malignancy risk stratification for solitary pulmonary nodule.

4 Jul, 2022 | 12:33h | UTC

Malignancy risk stratification for solitary pulmonary nodule: A clinical practice guideline – Journal of Evidence-Based Medicine


Brief Review | Ventilator-associated pneumonia.

4 Jul, 2022 | 12:15h | UTC

Ventilator-associated pneumonia – Intensive Care Medicine (if the link is paywalled, try this one in PMC)

 

Commentary on Twitter


2022 Guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.

1 Jul, 2022 | 11:50h | UTC

2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 – The Lancet Oncology

Related:

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy – Cochrane Library

American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer – Blood Advances

Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network

Venous and Arterial Thromboembolism in Patients With Cancer: JACC: CardioOncology State-of-the-Art Review

 


Two new studies show no benefit of Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19.

1 Jul, 2022 | 11:49h | UTC

Study 1: Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial – The Lancet Haematology

Study 2: Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial – The Lancet Haematology

Commentaries:

Antithrombotic prophylaxis for symptomatic outpatients with COVID-19: less is consistently more – The Lancet Haematology

Antithrombotic Prophylaxis No Help in Outpatients With COVID — Two trials show no differences between patients who received enoxaparin vs standard of care – MedPage Today (free registration required)

 

Commentary on Twitter (thread – click for more)

 


Accuracy of rapid antigen vs. RT-PCR testing for SARS-CoV-2 infection in college athletes during prevalence of the Omicron variant.

1 Jul, 2022 | 11:39h | UTC

Accuracy of Rapid Antigen vs Reverse Transcriptase–Polymerase Chain Reaction Testing for SARS-CoV-2 Infection in College Athletes During Prevalence of the Omicron Variant – JAMA Network Open

 

Commentary on Twitter

 


Review: Nutrition management for critically ill adult patients requiring non-invasive ventilation.

1 Jul, 2022 | 10:42h | UTC

Nutrition Management for Critically Ill Adult Patients Requiring Non-Invasive Ventilation: A Scoping Review – Nutrients

 


Life’s Essential 8: Updating and enhancing the AHA construct of cardiovascular health.

30 Jun, 2022 | 11:31h | UTC

Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association – Circulation

News Release: American Heart Association adds sleep to cardiovascular health checklist

Commentary: Sleep duration matters for heart health, according to new recommendations – CNN

Related Study: Status of Cardiovascular Health in US Adults and Children Using the American Heart Association’s New “Life’s Essential 8” Metrics: Prevalence Estimates from the National Health and Nutrition Examination Survey (NHANES), 2013-2018 – Circulation

 


Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis.

30 Jun, 2022 | 11:26h | UTC

Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis – The BMJ

 


Wearable activity trackers plus AI might be used to pick up presymptomatic COVID-19.

30 Jun, 2022 | 11:18h | UTC

News Release: Wearable activity trackers + AI might be used to pick up presymptomatic COVID-19 – BMJ Newsroom

Original Study: Investigation of the use of a sensor bracelet for the presymptomatic detection of changes in physiological parameters related to COVID-19: an interim analysis of a prospective cohort study (COVI-GAPP) – BMJ Open

 


Expert consensus: Diaphragm ultrasonography in the critically ill.

30 Jun, 2022 | 11:04h | UTC

EXpert consensus On Diaphragm UltraSonography in the critically ill (EXODUS): a Delphi consensus statement on the measurement of diaphragm ultrasound-derived parameters in a critical care setting – Critical Care

 


Case-Control Study: Outcomes and risk factors for delayed-onset postoperative respiratory failure.

30 Jun, 2022 | 10:34h | UTC

Outcomes and risk factors for delayed-onset postoperative respiratory failure: a multi-center case-control study by the University of California Critical Care Research Collaborative (UC3RC) – BMC Anesthesiology

 


RCT: A 2-week interruption in methotrexate treatment doubles the antibody response to a COVID-19 booster vaccine.

29 Jun, 2022 | 12:10h | UTC

Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial – The Lancet Respiratory Medicine

News Releases:

Interrupting the treatment of vulnerable people on immune-suppressing medicines, doubles their antibody response to COVID-19 booster vaccination – University of Nottingham

Interrupting immune-suppressing treatment can boost COVID vaccine response – Imperial College London

Commentaries:

Improving COVID-19 vaccine immunogenicity by interrupting methotrexate treatment – The Lancet Respiratory Medicine

Covid-19: Pausing immune suppressing drugs enhances antibody response to boosters, study shows – The BMJ

Related Study: Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial – Annals of Rheumatic Diseases

 

Commentary on Twitter

 


Perspective | Fast-evolving COVID variants complicate vaccine updates.

29 Jun, 2022 | 12:01h | UTC

Fast-evolving COVID variants complicate vaccine updates – Nature

 


Retrospective Cohort Study: Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation.

29 Jun, 2022 | 11:54h | UTC

Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation – Critical Care

 


An analysis of SARS-CoV-2 vaccine reactogenicity: variation by type, dose, and history, severity, and recency of prior SARS-CoV-2 infection.

29 Jun, 2022 | 11:52h | UTC

An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection – Open Forum Infectious Diseases

 


Systematic Review: Exercise versus airway clearance techniques for people with cystic fibrosis.

29 Jun, 2022 | 11:10h | UTC

Exercise versus airway clearance techniques for people with cystic fibrosis – Cochrane Library

Summary: Exercise versus airway clearance for people with cystic fibrosis – Cochrane Library

 


Brief Review: Noninvasive respiratory support in intensive care medicine.

29 Jun, 2022 | 11:06h | UTC

Noninvasive respiratory support in intensive care medicine – Intensive Care Medicine (if the link is paywalled, try this one)

 

Commentary on Twitter

 


Systematic Review: Trastuzumab Deruxtecan-induced interstitial lung disease/pneumonitis in ERBB2-positive advanced solid malignancies.

29 Jun, 2022 | 10:59h | UTC

Trastuzumab Deruxtecan-Induced Interstitial Lung Disease/Pneumonitis in ERBB2-Positive Advanced Solid Malignancies: A Systematic Review – Drugs

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.